DE69205687T2 - Dosierungsform fuer die freisetzung eines witkstoffs in einem kurzen zeitraum. - Google Patents
Dosierungsform fuer die freisetzung eines witkstoffs in einem kurzen zeitraum.Info
- Publication number
- DE69205687T2 DE69205687T2 DE69205687T DE69205687T DE69205687T2 DE 69205687 T2 DE69205687 T2 DE 69205687T2 DE 69205687 T DE69205687 T DE 69205687T DE 69205687 T DE69205687 T DE 69205687T DE 69205687 T2 DE69205687 T2 DE 69205687T2
- Authority
- DE
- Germany
- Prior art keywords
- dosage
- fuel
- release
- short period
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/747,899 US5178867A (en) | 1991-08-19 | 1991-08-19 | Dosage form for delivering drug in short-time period |
PCT/US1992/007034 WO1993003711A1 (en) | 1991-08-19 | 1992-08-19 | Dosage form for delivering drug in short-time period |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69205687D1 DE69205687D1 (de) | 1995-11-30 |
DE69205687T2 true DE69205687T2 (de) | 1996-04-11 |
Family
ID=25007151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69205687T Expired - Fee Related DE69205687T2 (de) | 1991-08-19 | 1992-08-19 | Dosierungsform fuer die freisetzung eines witkstoffs in einem kurzen zeitraum. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5178867A (de) |
EP (1) | EP0600033B1 (de) |
JP (1) | JP2934505B2 (de) |
AT (1) | ATE129404T1 (de) |
AU (1) | AU666674B2 (de) |
CA (1) | CA2112679C (de) |
DE (1) | DE69205687T2 (de) |
DK (1) | DK0600033T3 (de) |
ES (1) | ES2079206T3 (de) |
FI (1) | FI940787A (de) |
GR (1) | GR3017891T3 (de) |
MX (1) | MX9204776A (de) |
NO (1) | NO940376L (de) |
NZ (1) | NZ244009A (de) |
PT (1) | PT100789A (de) |
WO (1) | WO1993003711A1 (de) |
ZA (1) | ZA926241B (de) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) * | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
ATE208615T1 (de) * | 1993-07-09 | 2001-11-15 | Scherer Corp R P | Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen |
US5536505A (en) * | 1993-12-15 | 1996-07-16 | Eastman Chemical Company | Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends |
US5523095A (en) * | 1993-12-15 | 1996-06-04 | Eastman Chemical Company | Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends |
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
DE69631834T2 (de) * | 1995-09-21 | 2005-02-10 | Pharma Pass Ii Llc, Irvine | Neues ein säureempfindliches benzimidazol enthaltendes mittel und verfahren zu dessen herstellung |
JP2001524131A (ja) * | 1997-05-09 | 2001-11-27 | セイジ、ファーマスーティカルズ、インク | 安定な経口医薬品剤形 |
DE19747261A1 (de) * | 1997-10-25 | 1999-04-29 | Bayer Ag | Osmotisches Arzneimittelfreisetzungssystem |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6099859A (en) | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
US6524620B2 (en) | 1998-07-20 | 2003-02-25 | Andrx Pharmaceuticals, Inc. | Diltiazem controlled release formulation and method of manufacture |
US7094426B2 (en) * | 1998-08-27 | 2006-08-22 | Sage Pharmaceuticals, Inc. | Stable oral pharmaceutical dosage forms |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6099862A (en) * | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6780880B1 (en) * | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6326384B1 (en) * | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
FR2797767B1 (fr) * | 1999-08-27 | 2002-06-14 | Centre Nat Rech Scient | Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
JP2003518487A (ja) | 1999-12-23 | 2003-06-10 | ファイザー・プロダクツ・インク | ヒドロゲル駆動型積層薬物製剤 |
US6669954B2 (en) | 2000-01-25 | 2003-12-30 | John R. Crison | Controlled release of drugs |
US6866866B1 (en) * | 2000-11-03 | 2005-03-15 | Andrx Labs, Llc | Controlled release metformin compositions |
US6790459B1 (en) | 2000-11-03 | 2004-09-14 | Andrx Labs, Llc | Methods for treating diabetes via administration of controlled release metformin |
CA2427195C (en) | 2000-11-03 | 2009-10-06 | Andrx Corporation | Controlled release metformin compositions |
US20060034922A1 (en) * | 2000-11-03 | 2006-02-16 | Andrx Labs, Llc | Controlled release metformin compositions |
AU2003241537A1 (en) * | 2002-05-23 | 2003-12-12 | Andrx Corporation | Biguanide formulations |
US20040005359A1 (en) * | 2002-06-27 | 2004-01-08 | Cheng Xiu Xiu | Controlled release oral dosage form |
KR101363679B1 (ko) | 2002-09-20 | 2014-02-14 | 안드렉스 랩스 엘엘씨 | 약제학적 정제 |
US20050051922A1 (en) * | 2002-09-20 | 2005-03-10 | Avinash Nangia | Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same |
WO2004066924A2 (en) * | 2003-01-24 | 2004-08-12 | Andrx Labs Llc | Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
TWI372066B (en) * | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
US7051606B2 (en) * | 2004-01-30 | 2006-05-30 | Andrx Labs Llc | Dosage form holder device and methods for immersion testing |
EP1768668A2 (de) | 2004-06-16 | 2007-04-04 | Tap Pharmaceutical Products, Inc. | Multi-ppi-dosierform |
US20050287185A1 (en) * | 2004-06-23 | 2005-12-29 | David Wong | Extended release oxybutynin formulation |
US20070287740A1 (en) * | 2005-05-25 | 2007-12-13 | Transcept Pharmaceuticals, Inc. | Compositions and methods of treating middle-of-the night insomnia |
US8242131B2 (en) * | 2005-05-25 | 2012-08-14 | Transcept Pharmaceuticals, Inc. | Methods of treating middle-of-the-night insomnia |
US20070225322A1 (en) * | 2005-05-25 | 2007-09-27 | Transoral Pharmaceuticals, Inc. | Compositions and methods for treating middle-of-the night insomnia |
DE102005031577A1 (de) | 2005-07-06 | 2007-01-11 | Bayer Healthcare Ag | Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten |
WO2007065559A1 (en) * | 2005-11-18 | 2007-06-14 | Synthon B.V. | Zolpidem tablets |
RU2013106514A (ru) * | 2007-10-12 | 2015-03-10 | Такеда Фармасьютикалз Норт Америка, Инк. | Способы лечения нарушений желудочно-кишечного тракта независимо от потребления пищи |
DE102008059206A1 (de) | 2008-11-27 | 2010-06-10 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum |
SG11201406363VA (en) | 2012-05-07 | 2014-11-27 | Bayer Pharma AG | Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil |
EP4037666B1 (de) | 2020-12-08 | 2024-05-01 | Ruminant Biotech Corp Limited | Verbesserungen an vorrichtungen und verfahren zur abgabe von substanzen an tiere |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2799241A (en) * | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4063064A (en) * | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4519801A (en) | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
US4576604A (en) * | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
US4612008A (en) * | 1983-05-11 | 1986-09-16 | Alza Corporation | Osmotic device with dual thermodynamic activity |
US4693895A (en) * | 1984-10-26 | 1987-09-15 | Alza Corporation | Colon delivery system |
US4608048A (en) * | 1984-12-06 | 1986-08-26 | Alza Corporation | Dispensing device with drug delivery patterns |
DE3766885D1 (en) * | 1986-04-17 | 1991-02-07 | Alza Corp | Chlorpheniramine therapie. |
US4948592A (en) * | 1986-05-09 | 1990-08-14 | Alza Corporation | Pulsed drug delivery |
US4801461A (en) * | 1987-01-28 | 1989-01-31 | Alza Corporation | Pseudoephedrine dosage form |
NZ226822A (en) * | 1987-11-16 | 1990-03-27 | Mcneil Consumer Prod | Chewable medicament tablet containing means for taste masking |
US4931285A (en) * | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
-
1991
- 1991-08-19 US US07/747,899 patent/US5178867A/en not_active Expired - Lifetime
-
1992
- 1992-08-18 MX MX9204776A patent/MX9204776A/es active IP Right Grant
- 1992-08-19 EP EP92919273A patent/EP0600033B1/de not_active Expired - Lifetime
- 1992-08-19 DK DK92919273.0T patent/DK0600033T3/da active
- 1992-08-19 NZ NZ244009A patent/NZ244009A/en unknown
- 1992-08-19 PT PT100789A patent/PT100789A/pt not_active Application Discontinuation
- 1992-08-19 WO PCT/US1992/007034 patent/WO1993003711A1/en active IP Right Grant
- 1992-08-19 AU AU25449/92A patent/AU666674B2/en not_active Ceased
- 1992-08-19 ZA ZA926241A patent/ZA926241B/xx unknown
- 1992-08-19 DE DE69205687T patent/DE69205687T2/de not_active Expired - Fee Related
- 1992-08-19 AT AT92919273T patent/ATE129404T1/de not_active IP Right Cessation
- 1992-08-19 CA CA002112679A patent/CA2112679C/en not_active Expired - Fee Related
- 1992-08-19 JP JP5504590A patent/JP2934505B2/ja not_active Expired - Fee Related
- 1992-08-19 ES ES92919273T patent/ES2079206T3/es not_active Expired - Lifetime
-
1994
- 1994-02-07 NO NO940376A patent/NO940376L/no unknown
- 1994-02-18 FI FI940787A patent/FI940787A/fi not_active Application Discontinuation
-
1995
- 1995-10-26 GR GR950402687T patent/GR3017891T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH06509809A (ja) | 1994-11-02 |
DE69205687D1 (de) | 1995-11-30 |
PT100789A (pt) | 1994-05-31 |
JP2934505B2 (ja) | 1999-08-16 |
GR3017891T3 (en) | 1996-01-31 |
ZA926241B (en) | 1993-10-04 |
EP0600033B1 (de) | 1995-10-25 |
CA2112679C (en) | 2003-04-15 |
AU2544992A (en) | 1993-03-16 |
NO940376D0 (no) | 1994-02-07 |
NZ244009A (en) | 1995-02-24 |
ES2079206T3 (es) | 1996-01-01 |
EP0600033A1 (de) | 1994-06-08 |
US5178867A (en) | 1993-01-12 |
DK0600033T3 (da) | 1995-12-27 |
AU666674B2 (en) | 1996-02-22 |
CA2112679A1 (en) | 1993-03-04 |
FI940787A0 (fi) | 1994-02-18 |
FI940787A (fi) | 1994-02-18 |
WO1993003711A1 (en) | 1993-03-04 |
ATE129404T1 (de) | 1995-11-15 |
NO940376L (no) | 1994-02-07 |
MX9204776A (es) | 1993-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69205687T2 (de) | Dosierungsform fuer die freisetzung eines witkstoffs in einem kurzen zeitraum. | |
CO4750822A1 (es) | Formulaciones farmaceuticas tada para la administracion en el tracto gastrointestinal y procesos para elaborar las mismas | |
ATE165000T1 (de) | Dosierungsform zur verzoegerten wirkstofffreisetzung | |
DE69101314T2 (de) | Dosierungsform zur verabreichung eines arzneimittels an die därme. | |
DK0600079T3 (da) | Oral 1alpha-hydroxyprævitamin D | |
DE69212879T2 (de) | Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren | |
DE69003392T2 (de) | Dosisform zur oralen verabreichung des hypoglykämischen glipizids. | |
NZ503946A (en) | Oral dosage form in an oval or caplet shape for administration of bisphosphonates and other known medicaments | |
KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
ES2139132T3 (es) | Composiciones farmaceuticas activas en la terapia de desordenes del sueño. | |
ITMI951359A0 (it) | Formulazioni farmaceutiche e dietetiche per la profilassi e la cura di affezioni gastrointestinali | |
RU93051537A (ru) | Перорально вводимая лекарственная форма | |
CS545686A1 (en) | Farmaceuticky prostredek a antihepatotoxickym pusobenim | |
MX9100080A (es) | Composiciones farmaceuticas y metodos para aliviar sintomas gastrointestinales inducidos por drogas antiinflamatorias no esteroidales | |
KR970061244A (ko) | 치매 치료용 약학 조성물 | |
EP0438147A3 (en) | Pharmaceutical compositions and dosage forms for the oral administration of calcitonin | |
EP0207011A3 (en) | Use of some alkanoyl l-carnitines for the therapeutical treatment of idiopathic and induced parkinsonism | |
MX9100072A (es) | Composiciones farmaceuticas y metodos para aliviar sintomas de dolores gastrointestinales inducidos por drogas antiinflamatorias no esteroidales | |
ES538982A0 (es) | Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas. | |
KR900009029A (ko) | 가축병 치료용 약물을 투여하는 장치 | |
SE8705136D0 (sv) | Oral doseringsenhet for lekemedel och dess anvendning och framstellning | |
ES2101311T3 (es) | Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer. | |
IT1267664B1 (it) | Composizione a base di fosfocreatina e suo uso farmaceutico | |
IT1271354B (it) | Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi | |
RU95117047A (ru) | Гибкий провод для лечения лекарствами заболевания язва желудка |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |